Cargando…
Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection
Cancer research has been righteously and successfully focused on prevention, early detection and identification of specific molecular targets that distinguish the malignant cells from the neighboring benign cells(1). However, a major clinical challenge concerns how we can reduce lethal tissue injury...
Autores principales: | Zhou, Wei-Jie, Geng, Zhen H., Spence, Jason R., Geng, Jian-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888063/ https://www.ncbi.nlm.nih.gov/pubmed/23903657 http://dx.doi.org/10.1038/nature12416 |
Ejemplares similares
-
The relevance of plasma R-spondin 1 and Slit2 as predictive biomarkers in cervical cancer chemotherapy and radiotherapy
por: Nie, Jichan, et al.
Publicado: (2021) -
HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5(+) liver stem cells
por: Lin, Yuan, et al.
Publicado: (2017) -
Intestinal Lymphatic Endothelial Cells Produce R-Spondin3
por: Ogasawara, Reiki, et al.
Publicado: (2018) -
Transit-amplifying cells control R-spondins in the mouse crypt to modulate intestinal stem cell proliferation
por: Chaves-Pérez, Almudena, et al.
Publicado: (2022) -
Intestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1
por: Tamminen, Kaisa, et al.
Publicado: (2015)